节点文献

新3,5-二取代噁唑烷酮抗菌剂的合成及其体外抑菌活性

Synthesis and in vitro antibacterial activities of new 3,5-disubstituted oxazolidinone compounds

  • 推荐 CAJ下载
  • PDF下载
  • 不支持迅雷等下载工具,请取消加速工具后下载。

【作者】 孟庆国王琪刘浚

【Author】 MENG Qing guo 1* , WANG Qi 2, LIU Jun 1 (1. Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China; 2. Institute of Clinical Pharmacology, No 1 Hospital of Peking University, Beijing 100034, China)

【机构】 中国医学科学院、中国协和医科大学医药生物技术研究所北京大学第一医院临床药理研究所中国医学科学院、中国协和医科大学医药生物技术研究所 北京100050北京100034北京100050

【摘要】 目的 设计、合成唑烷酮新化合物并测定其体外抑菌活性。方法 对文献方法进行了改进 ,在文献报道的构效关系基础上 ,设计、合成唑烷酮新化合物并测定体外抑菌活性。结果 合成了 39个新化合物 ,其中目标物 1 8个 ,其结构经IR ,1 HNMR ,MS等方法确证。 1 6个化合物显示出较好的抑菌活性 ,其中化合物 9,1 0 ,1 0b对 4种试验菌的MIC50 和MIC90 值小于或接近 4种对照药 ,化合物 9a和 1 1c没有抑菌活性。结论 化合物 9,1 0和 1 0b值得进一步研究。

【Abstract】 Aim To design and synthesize new oxazolidinone antibacterial agents. Methods The synthetic method reported in literature has been modified and new 3,5 disubstituted oxazolidinone compounds were synthesized on the basis of SAR reported in the literature and their antibacterial activities in vitro were determined. Results Eighteen new objective compounds were synthesized, and their structures were determined by IR, 1HNMR and FAB MS. Within the eighteen new objective compounds, sixteen compounds showed antibacterial activity in vitro and compound 9, 10 and 10b showed better antibacterial activities in vitro than ciprofloxacin (CIP), sultamicillin (Sul) and vancomycin (VCO). Compounds 9a and 11c have no antibacterial activity in vitro at all. Conclusion Compounds 9, 10 and 10b are worthy to be intensively studied.

【关键词】 噁唑烷酮抑菌剂合成抑菌活性
【Key words】 oxazolidinoneantibioticsynthesisantibacterial activity
  • 【文献出处】 药学学报 ,Acta Pharmaceutica Sinica , 编辑部邮箱 ,2003年10期
  • 【分类号】R914;R96
  • 【被引频次】6
  • 【下载频次】213
节点文献中: 

本文链接的文献网络图示:

本文的引文网络